PUBLICATIONS UPDATE
Latest update (Feb 2024): In collaboration with Drs. Guido Kromer and Jonathan Pol (INSERM, Paris, France], and Elsevier’s journal Seminars In Immunology ( https://www.journals.elsevier.com/seminars-in-immunology), we have embarked on an exciting mission to create a special issue on ‘Oncolytic virus-induced immune responses’. Using this special issue, we hope to create a compendium on OV immunotherapy through the lens of selected leading OV experts at various international institutes.
We hope that you can give a kind consideration to our invitation and contribute your valuable input within this important compendium on OV immunotherapy.
Our perspective on OV cancer immunotherapy is highlighted within following publications:
GUJAR S*, Pol J*, Kumar V, Lizarralde-Guerrero M, Konda P, Kroemer G, Bell J. Tutorial: Design, Production and Testing of Oncolytic Viruses for Cancer Immunotherapy. Nature Protocols. 2024. Accepted.
GUJAR S, Bell J and Diallo JS. Cancer immunotherapy with oncolytic viruses. Cell. 2019. [PMID: 30794777].
GUJAR S*, Pol J*, Kim Y, Lee P and Kroemer G. 2018. Antitumor benefits of antiviral immunity: an underappreciated aspect of oncolytic virotherapies. Trends in Immunology. 2018 (Cell Press). S1471-4906(17)30228-4. [Selected as the cover feature of March 2018 issue of the journal, and also highlighted on Cell.com]. [PMID: 29275092].
Lee P and GUJAR S. 2018. Potentiating prostate cancer immunotherapy with oncolytic viruses. Nature Reviews Urology. 2018. [Featured on the cover page of April 2018 issue of the journal]. [PMID: 29434366].
Full list of our publications can be found here:
https://www.ncbi.nlm.nih.gov/myncbi/1J9D7vxzpMy5T/bibliography/public/
For more publications: Pubmed
See our article highlighted on Cell.com, and featured on the cover page of Trends in Immunology